Dr. Roos has 12 years of research and discovery experience, with more than five of those in biotechnology. Prior to joining CalciMedica, Dr. Roos was Principal Scientist at TorreyPines Therapeutics. Dr. Roos, along with Dr. Stauderman, co-authored the discovery of STIM1, which has an essential role in CRAC channel activity and which is important for immune cell activation.
Dr. Roos has published over 20
peer-reviewed articles and reviews. Dr. Roos received his BA in
Biochemistry and Cell Biology from UCSD, his PhD in Biochemistry
and Molecular Biology from SUNY/Stony Brook and completed his
postdoctoral studies in the Department of Biochemistry and Biophysics
at UCSF.
